Home
Our Society
Board Members
ByLaws
Founding Members
Member List
Membership Form
Media
Press
News
Congress
Upcoming Congress
Previous Congress
Projects
Endo At School
The Higher Education Credit and Hostels Instituton
Corporate Awareness Meetings
EndoMarch
Library
Presentations
Journals
Videos
Article Summaries
Contact
+90 532 515 69 99
info@endometriozisdernegi.org
Youtube
Instagram
Facebook
Twitter
Linkedin
For Patients
Home
Our Society
Board Members
ByLaws
Founding Members
Member List
Membership Form
Media
Press
News
Congress
Upcoming Congress
Previous Congress
Projects
Endo At School
The Higher Education Credit and Hostels Instituton
Corporate Awareness Meetings
EndoMarch
Library
Presentations
Journals
Videos
Article Summaries
Links
Guidelines
Bulletins
Books
Presentations
Journals
Videos
Article Summaries
Contact
Home
Our Society
Board Members
ByLaws
Founding Members
Member List
Membership Form
Media
Press
News
Congress
Upcoming Congress
Previous Congress
Projects
Endo At School
The Higher Education Credit and Hostels Instituton
Corporate Awareness Meetings
EndoMarch
Library
Presentations
Journals
Videos
Article Summaries
Links
Guidelines
Bulletins
Books
Presentations
Journals
Videos
Article Summaries
Contact
Summary of Articles in March 2017
Article Summaries
1- Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis. Hum Reprod 2017 Feb 9:1-14. doi: 10.1093/humrep/dex024.
2- Soluble VCAM-1/soluble ICAM-1 ratio is a promising biomarker for diagnosing endometriosis. Hum Reprod 2017 Feb 23:1-10. doi: 10.1093/humrep/dex028.
3- Endometriosis education in schools: A New Zealand model examining the impact of an education program in schools on early recognition of symptoms suggesting endometriosis. Aust N Z J Obstet Gynaecol. 2017 Mar 28. doi: 10.1111/ajo.12614.
4- Non-ART pregnancy predictive factors in infertile patients with peritoneal superficial endometriosis. Eur J Obstet Gynecol Reprod Biol 2017 Mar 7;211:182-187. doi: 10.1016/j.ejogrb.2017.03.008.
5- Endometriosis is associated with aberrant metabolite profiles in plasma. Fertil Steril 2017 Mar;107(3):699-706.e6. doi: 10.1016/j.fertnstert.2016.12.032.
6- Introduction: A focus on the medical management of endometriosis. Fertil Steril 2017 Mar;107(3):521-522. doi: 10.1016/j.fertnstert.2017.01.008.
7- Mu opioid receptor in the human endometrium: dynamics of its expression and localization during the menstrual cycle. Fertil Steril 2017 Feb 27. pii: S0015-0282(17)30079-1. doi: 10.1016/j.fertnstert.2017.01.020.
8- Clinicians' perceptions of women's experiences of endometriosis and of psychosocial care for endometriosis. Aust N Z J Obstet Gynaecol 2017 Feb;57(1):87-92. doi: 10.1111/ajo.12571.
9- Genetic risk factors for ovarian cancer and their role for endometriosis risk. Gynecol Oncol 2017 Apr;145(1):142-147. doi: 10.1016/j.ygyno.2017.02.022.
10- Biomarkers in endometriosis: challenges and opportunities. Fertil Steril 2017 Mar;107(3):523-532. doi: 10.1016/j.fertnstert.2017.01.009.
11- Surgery for endometriosis: beyond medical therapies. Fertil Steril 2017 Mar;107(3):549-554. doi: 10.1016/j.fertnstert.2017.01.001.
12- Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescents. J Pediatr Adolesc Gynecol 2017 Feb 9. pii: S1083-3188(17)30036-0. doi: 10.1016/j.jpag.2017.01.014.
13- Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril 2017 Mar;107(3):533-536. doi: 10.1016/j.fertnstert.2017.01.003.
14- Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy. Fertil Steril 2017 Mar;107(3):537-548. doi: 10.1016/j.fertnstert.2016.12.024.
15- Does preoperative antimüllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis? Fertil Steril 2017 Mar;107(3):707-713.e3. doi: 10.1016/j.fertnstert.2016.12.013.
16- Prognostic factors for assisted reproductive technology in women with endometriosis-related infertility. Am J Obstet Gynecol 2017 Mar;216(3):280.e1-280.e9. doi: 10.1016/j.ajog.2016.11.1042.
17- Effects of long-term postoperative dienogest use for treatment of endometriosis on bone mineral density. Eur J Obstet Gynecol Reprod Biol 2017 Mar 6;212:9-12. doi: 10.1016/j.ejogrb.2017.03.011.
18- Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission. Eur J Obstet Gynecol Reprod Biol 2017 Apr;211:108-111. doi: 10.1016/j.ejogrb.2017.02.015.
19- Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses. Cancer Causes Control 2017 Mar 15. doi: 10.1007/s10552-017-0856-4.